Skip to content

Evaluation on curative effect of Chinese medicine characteristic diagnosis and technique for knee osteoarthritis with knee deformity

Evaluation on curative effect of Chinese medicine characteristic diagnosis and technique for knee osteoarthritis with knee deformity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006498
Enrollment
Unknown
Registered
2022-08-15
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

Experimental group(remission stage) :Oral administration of traditional Chinese medicine granules
Control group(stable stage):Rehabilitation exercise
Control group (remission stage) :Intra articular injection with odium hyaluronate
Control group(acute stage):Oral anti-inflammatory drug therapy
Experimental group(acute stage):Oral administration of traditional Chinese medicine granules
Experimental group(stable stage):Ba Duan Jin exercise
Experimental group(acute stage):Acupotomy
Control group(acute stage):Intra articular injection with odium hyaluronate

Sponsors

Beijing University of Chinese Medicine Third Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Conform to the western medicine diagnosis of knee osteoarthritis and KL stage I-III 2. It is consistent with the syndrome and symptom combination stage of knee osteoarthritis 3. Age 40 to 70 4. The flexion deformity is less than 30 degrees, and the varus and valgus deformity are less than 10 degrees

Exclusion criteria

Exclusion criteria: 1. People who are known to have a history of allergy to drugs with similar components and chemical structures contained in the test drug or control drug 2. Patients with liver and kidney insufficiency 3. Patients with hematopoietic system diseases 4. Diabetes, Cushing's syndrome and other endocrine diseases 5. Patients with serious heart and brain diseases 6. Patients with low immunity; 7. Staff directly involved in this study; 8. Pregnant or fertile women with positive pregnancy test and lactating women; 9. Those who are currently participating in other clinical studies or have participated in other clinical studies within 3 months; 10. Other conditions that the researcher judges are not suitable for clinical research

Design outcomes

Primary

MeasureTime frame
VAS score;TCM syndrome classification score;

Secondary

MeasureTime frame
Knee varus angle;WOMAC score;Knee flexion angle;

Countries

China

Contacts

Public ContactChen Weiheng
drchenweiheng@163.com13511013261

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026